Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1.

Mohan J, Dement-Brown J, Maier S, Ise T, Kempkes B, Tolnay M.

Blood. 2006 Jun 1;107(11):4433-9. Epub 2006 Jan 26.

2.

Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

Hsieh JJ, Hayward SD.

Science. 1995 Apr 28;268(5210):560-3.

PMID:
7725102
3.

Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

Strobl LJ, Höfelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U.

J Virol. 2000 Feb;74(4):1727-35.

4.

Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells.

Pagès F, Galon J, Karaschuk G, Dudziak D, Camus M, Lazar V, Camilleri-Broët S, Lagorce-Pagès C, Lebel-Binay S, Laux G, Fridman WH, Henglein B.

Blood. 2005 Feb 15;105(4):1632-9. Epub 2004 Oct 21.

5.

Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.

Kohlhof H, Hampel F, Hoffmann R, Burtscher H, Weidle UH, Hölzel M, Eick D, Zimber-Strobl U, Strobl LJ.

Blood. 2009 May 28;113(22):5506-15. doi: 10.1182/blood-2008-11-190090. Epub 2009 Apr 1.

7.

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

Henkel T, Ling PD, Hayward SD, Peterson MG.

Science. 1994 Jul 1;265(5168):92-5.

PMID:
8016657
8.

Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2.

Sakai T, Taniguchi Y, Tamura K, Minoguchi S, Fukuhara T, Strobl LJ, Zimber-Strobl U, Bornkamm GW, Honjo T.

J Virol. 1998 Jul;72(7):6034-9.

9.

EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Gordadze AV, Onunwor CW, Peng R, Poston D, Kremmer E, Ling PD.

J Virol. 2004 Apr;78(8):3919-29.

10.

Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter.

Voss MD, Hille A, Barth S, Spurk A, Hennrich F, Holzer D, Mueller-Lantzsch N, Kremmer E, Grässer FA.

J Virol. 2001 Dec;75(23):11781-90.

11.
12.

Epigenetic regulation of lymphoid specific gene sets.

Györy I, Minarovits J.

Biochem Cell Biol. 2005 Jun;83(3):286-95. Review.

PMID:
15959556
13.

The CR4 region of EBNA2 confers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling.

Grabusic K, Maier S, Hartmann A, Mantik A, Hammerschmidt W, Kempkes B.

J Gen Virol. 2006 Nov;87(Pt 11):3169-76.

PMID:
17030849
14.

Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

Lucchesi W, Brady G, Dittrich-Breiholz O, Kracht M, Russ R, Farrell PJ.

J Virol. 2008 Aug;82(15):7456-66. doi: 10.1128/JVI.00223-08. Epub 2008 May 14.

16.

EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.

Zimber-Strobl U, Strobl LJ.

Semin Cancer Biol. 2001 Dec;11(6):423-34. Review.

PMID:
11669604
17.

Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.

Larcher C, Kempkes B, Kremmer E, Prodinger WM, Pawlita M, Bornkamm GW, Dierich MP.

Eur J Immunol. 1995 Jun;25(6):1713-9.

PMID:
7614999
18.
19.

Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

Farrell CJ, Lee JM, Shin EC, Cebrat M, Cole PA, Hayward SD.

Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4625-30. Epub 2004 Mar 19. Erratum in: Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13694.

Supplemental Content

Support Center